|
|||||
|
|
FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage repair |
|
| Authors: | Shu-Ping Wang Shi-Qi Wu Shi-Hui Huang Yi-Xuan Tang Liu-Qiong Meng Feng Liu Qi-Hua Zhu Yun-Gen Xu |
| Institution: | 1.State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, 211198 Nanjing, China ;2.Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, 210009 China |
| Abstract: | |
| Keywords: | |